TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

(2021) András Lánczky et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

A Potential Role for HUWE1 in Modulating Cisplatin Sensitivity

(2021) Stijn Wenmaekers et al.   Cells

Photobiomodulation With Blue Laser Inhibits Bladder Cancer Progression

(2021) Yuqi Xia et al.   Frontiers in Oncology

EMT and Back Again: Visualizing the Dynamic Phenotypes of Metastasis

(2020) Fred Bunz   CANCER RESEARCH

Treatment of muscle‐invasive and advanced bladder cancer in 2020

(2020) Vaibhav G. Patel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance

(2020) Milad Ashrafizadeh et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

TFAP2C facilitates somatic cell reprogramming by inhibiting c-Myc-dependent apoptosis and promoting mesenchymal-to-epithelial transition

(2020) Yuan Wang et al.   Cell Death & Disease

METTL3 potentiates resistance to cisplatin through m 6 A modification of TFAP2C in seminoma

(2020) Jingchao Wei et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Bladder Cancer

(2020) Andrew T. Lenis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression

(2019) Zhixin Huang et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers

(2019) Damian Kołat et al.   BIOSCIENCE REPORTS

Cisplatin: The first metal based anticancer drug

(2019) Sumit Ghosh   BIOORGANIC CHEMISTRY

Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy

(2019) Bingjun Sun et al.   Nature Communications

TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway

(2018) Xu Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

TFAP2C regulates transcription in human naive pluripotency by opening enhancers

(2018) William A. Pastor et al.   NATURE CELL BIOLOGY

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

(2017) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder

(2016) Wei-Jan Wang et al.   CLINICAL CANCER RESEARCH

Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement

(2016) Matthew I. Milowsky et al.   JOURNAL OF CLINICAL ONCOLOGY

EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib

(2016) J. P. De Andrade et al.   MOLECULAR CANCER THERAPEUTICS

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

(2016) Yuejun Tian et al.   PLoS One

The Genotype-Tissue Expression (GTEx) Project

(2015) Latarsha J. Carithers et al.   BIOPRESERVATION AND BIOBANKING

Mitochondrial apoptosis: killing cancer using the enemy within

(2015) J Lopez et al.   BRITISH JOURNAL OF CANCER

NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression

(2015) YI SUN et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Inhibition of autophagy using 3-methyladenine increases cisplatin-induced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells

(2015) RUIJIAN ZHANG et al.   Molecular Medicine Reports

The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis

(2015) J M Park et al.   ONCOGENE

EGFR and NF-κB: partners in cancer

(2015) Kateryna Shostak et al.   TRENDS IN MOLECULAR MEDICINE

The Genotype-Tissue Expression (GTEx) Project

(2015) Latarsha J. Carithers et al.   Biopreservation and Biobanking

S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy

(2014) W. T. Kim et al.   ANNALS OF ONCOLOGY

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors

(2013) Francesca Cavallo et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics

(2013) Linn Fagerberg et al.   MOLECULAR & CELLULAR PROTEOMICS

Molecular mechanisms of cisplatin resistance in bladder cancer

(2012) Ross M Drayton et al.   Expert Review of Anticancer Therapy

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

NCBI GEO: archive for functional genomics data sets—update

(2012) Tanya Barrett et al.   NUCLEIC ACIDS RESEARCH

Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer

(2011) C Alberti et al.   ONCOGENE

Oncogenic EGFR Signaling Activates an mTORC2-NF- B Pathway That Promotes Chemotherapy Resistance

(2011) K. Tanaka et al.   Cancer Discovery

The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin

(2010) Anamaria Brozovic et al.   CRITICAL REVIEWS IN TOXICOLOGY

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

(2010) Wun-Jae Kim et al.   Molecular Cancer

AP-2γ promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene

(2009) Christopher M J Williams et al.   EMBO JOURNAL

Cisplatin-Induced DNA Damage Activates Replication Checkpoint Signaling Components that Differentially Affect Tumor Cell Survival

(2009) J. M. Wagner et al.   MOLECULAR PHARMACOLOGY

AP2γ regulates basal progenitor fate in a region- and layer-specific manner in the developing cortex

(2009) Luisa Pinto et al.   NATURE NEUROSCIENCE

Current Status of Prognostic Immunohistochemical Markers for Urothelial Bladder Cancer

(2008) R. Rosenblatt et al.   TUMOR BIOLOGY

Distinctive Expression Pattern of ErbB Family Receptors Signifies an Aggressive Variant of Bladder Cancer

(2007) Wassim Kassouf et al.   JOURNAL OF UROLOGY